A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer

Clinical trial NCT05227664 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05227664
Sponsor: Akeso
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Triple-negative Breast Cancer Locally Advanced Triple-negative Breast Cancer

Start date: 2022-03-23
Primary completion: 2026-12-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.